Vijay Prasad

Vijay Prasad is currently a Global Clinical Program Leader at AstraZeneca, focusing on the global clinical development of antibody-drug conjugates and immunotherapy for breast cancer. Vijay received extensive training in medical oncology at leading cancer centers in the UK and completed a PhD in Immunology. Prior to this role, Vijay served as Clinical Director at Roche and Associate Director of Clinical Research at Eisai EMEA, contributing significantly to advances in cancer therapy. With a solid background in clinical academic oncology and cancer drug development, Vijay holds an MBBS and MRCP from the Royal College of Physicians, alongside a notable history of hands-on laboratory experience in immunotherapy and immuno-oncology.